India's drug regulator has approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use ... 印度本土生产的Covishield,印度Bharat Biotech研发的新冠疫苗Covaxin ...
Bharat Biotech CEO Krishna Ella and Serum Institute of India (SII) CEO Adar Poonawalla issued a joint statement today, pledging their commitment to making the COVID-19 vaccine available in India ...
Four of the six companies developing COVID vaccines in India are based in Hyderabad. Bharat Biotech is currently conducting Phase III clinical trials of India's first indigenous COVID-19 vaccine ...
Other companies with chikungunya vaccines in development include Bharat Biotech and, until recently, MSD, which abandoned its V184 candidate earlier this year. Chikungunya is a mosquito-borne ...